Tailored Vaccine Offers Cautious Hope in Ovarian Cancer Study Posted by By Florence Mitchell October 16, 2026 A phase 1 trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer — early data, not proof.
